健康大视野·医学分册2023,Issue(13) :23-24.DOI:10.3969/j.issn.1005-0019.2023.13.010

糖尿病早期肾损伤的诊断中应用尿糖联合尿微量白蛋白检验的效果分析与探讨

李庆友
健康大视野·医学分册2023,Issue(13) :23-24.DOI:10.3969/j.issn.1005-0019.2023.13.010

糖尿病早期肾损伤的诊断中应用尿糖联合尿微量白蛋白检验的效果分析与探讨

李庆友1
扫码查看

作者信息

  • 1. 莘县第三人民医院检验科,山东 聊城 252427
  • 折叠

摘要

目的:探讨尿糖(U-GLU)、尿微量白蛋白(MAU)在糖尿病(DM)早期肾损伤诊治工作中的具体应用价值.方法:选取2021年01月-2022年12月期间收治的240例患者作为研究对象.结果:研究组DM早期肾损伤患者U-GLU、MAU水平最高,对照2组健康体检者U-GLU、MAU水平最低,数据组间对比P<0.05(有统计学意义);研究组中U-GLU及MAU均阳性率(65.00%)高于对照1组、对照2组(分别为39.17%、5.83%),数据组间对比存在统计学意义(P<0.05).结论:DM早期肾

Abstract

Objective To explore the specific application value of urinary glucose (U-GLU) and urinary microalbumin (MAU) in the diagnosis and treatment of early renal injury in diabetes. Methods: 240 patients admitted from January 2021 to December 2022 were selected as the study subjects. Results: The levels of U-GLU and MAU in patients with early renal injury in DM in the study group were the highest, while those in the control group were the lowest. P< 0.05 (statistically significant); The positive rates of U-GLU and MAU in the study group (65.00%) were higher than those in the control group 1 and control group 2 (39.17% and 5.83% respectively), and there was statistical significance between the data groups (P< 0.05). Conclusion: The levels of U-GLU and MAU in patients with early renal injury in DM are high, and the results of U-GLU and MAU test are of great value in the diagnosis of early renal injury in DM.

关键词

糖尿病/早期肾损伤/尿糖/尿微量白蛋白/临床诊断

Key words

diabetes/Early renal injury/Urine sugar/Urine microalbumin/clinical diagnosis

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量7
段落导航相关论文